No Data
No Data
BTIG Maintains Athira(ATHA.US) With Hold Rating
Athira Pharma's Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained
Athira Pharma's 2024 Financial Results and Pipeline Progress
Athira Pharma (ATHA) Gets a Hold From JMP Securities
Express News | Athira Pharma FY 2024 GAAP EPS $(2.52) Beats $(2.54) Estimate
Athira | 10-K: FY2024 Annual Report